AI

Beiersdorf and Insilico join forces on AI research

Companies collaborate to discover novel, safe bioactive ingredients for skin indications - applying AI to advanced cosmetics: An important part of the Longevity ecosystem. Skin...

Cellular senescence: a precise biomarker in humans?

A world-first study shows that even though senescence is a key hallmark of chronological aging in humans, senescence levels may vary significantly between organs...

2020 outlook for Longevity technology

Will 2020 be the year that sees a step change in Longevity? We review technology readiness levels for key Longevity domains. Yep, we have a...

It’s all in the numbers; small sets of numbers

AI start-up NetraMark targets $3 million seed round while identifying that an exciting repurposing candidate has potential for indication expansion into Longevity. “I won’t tell you...

Latest articles

Insurer puts down £20m to research an aging rethink

A new partnership between Legal & General and Edinburgh University aims to address the societal and economic implications of an aging society. The world is...

23andMe redundancies: DNA test market decline?

Could layoffs at 23andMe be a sign that the consumer appetite for genetic testing is declining? We expect consumer markets to transition to more...

Singapore agetech – ones to watch in 2020

Singapore thrives on its prime location at the crossroads of Asia's biggest markets, low business tax and great IT infrastructure; it is well-positioned to...

Innovating organ-on-chip to accelerate research

BIOFABICS brings custom design tools to biofabrication. While still in its infancy, organ-on-chip (OOC) technology is quickly becoming a key growth segment in the Longevity...

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.